Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study

Fig. 3

Summary of SDAI categories over time in the intent-to-treat population during the induction period. Unknown status refers to the patients for whom data were not available at that particular time point. SDAI categories: remission, ≤ 3.3; low disease activity, > 3.3–11; moderate disease activity, > 11–26; high disease activity, > 26. MTX, methotrexate; SDAI, Simplified Disease Activity Index. Portions of panel A were previously presented at EULAR 2020 (poster FRI0090); copyright © the authors

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us